These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4923 related articles for article (PubMed ID: 4549213)
1. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells, de Vries JE; Cornain S; Rumke P Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213 [No Abstract] [Full Text] [Related]
2. Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells. Wybran J; Hellström I; Hellström KE; Fudenberg HH Int J Cancer; 1974 Apr; 13(4):515-21. PubMed ID: 4546321 [No Abstract] [Full Text] [Related]
3. Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells. Saal JG; Rieber EP; Hadam M; Riethmuller G Nature; 1977 Jan; 265(5590):158-60. PubMed ID: 299919 [No Abstract] [Full Text] [Related]
6. Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells. Yust I; Wunderlich JR; Mann DL; Buell DN J Immunol; 1973 Jun; 110(6):1672-81. PubMed ID: 4712926 [No Abstract] [Full Text] [Related]
7. The effects of proteolysis on the human immune mechanism in cancer. A preliminary communication. Thornes RD; Smyth H; Browne O; O'Gorman M; Reen DJ; Farrell D; Holland PD J Med; 1974; 5(1):92-7. PubMed ID: 4275505 [No Abstract] [Full Text] [Related]
8. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors. de Vries JE; Meyering M; van Dongen A; Rümke P Int J Cancer; 1975 Mar; 15(3):391-400. PubMed ID: 1056313 [TBL] [Abstract][Full Text] [Related]
9. Immunology of human malignant melanoma. Lewis MG Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040 [No Abstract] [Full Text] [Related]
10. Characterization of subpopulations of human lymphoid cells participating in phytohemagglutinin and concanavalin A-induced cytotoxicity. Wisloff F; Froland SS; Michaelsen TE Int Arch Allergy Appl Immunol; 1974; 47(4):488-97. PubMed ID: 4547156 [No Abstract] [Full Text] [Related]
11. Characterization of suppressor cells in mice with a transplantable malignant melanoma. Stelzer GT; Wallace JH Oncology; 1980; 37(6):397-405. PubMed ID: 6448970 [TBL] [Abstract][Full Text] [Related]
12. T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia. Brouet JC; Toben HR; Chevalier A; Seligmann M Ann Immunol (Paris); 1974; 125 C(5):691-6. PubMed ID: 4617552 [No Abstract] [Full Text] [Related]
13. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells. Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012 [TBL] [Abstract][Full Text] [Related]
14. [Surface receptors in human lymphocytes]. Nowak J Pol Arch Med Wewn; 1975 Jul; 54(1):55-66. PubMed ID: 50596 [No Abstract] [Full Text] [Related]
15. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations. O'Neill PA; Mackler BF; Romsdahl MM J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348 [TBL] [Abstract][Full Text] [Related]
16. A comparison of human lymphoid cells in antibody-dependent cellular cytotoxicity (ADCC). Gale RP; Zighelboim J; Ossorio RC; Fahey JL Clin Immunol Immunopathol; 1975 Jan; 3(3):377-84. PubMed ID: 1167324 [No Abstract] [Full Text] [Related]
17. In vitro correlates of cell-mediated immunity in the human. Bach JF Boll Ist Sieroter Milan; 1974; 53(1):suppl:161-73. PubMed ID: 4277530 [No Abstract] [Full Text] [Related]
18. Lymphocyte anergy in patients with carcinoma. Nind AP; Nairn RC; Rolland JM; Guli EP; Hughes ES Br J Cancer; 1973 Aug; 28(2):108-17. PubMed ID: 4581078 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for melanoma. Vaisrub S JAMA; 1973 Sep; 225(10):1242. PubMed ID: 4542440 [No Abstract] [Full Text] [Related]